inola F® on Skin Physiology of patients with atopic dermatitis
- Conditions
- Atopic dermatitis with mild to moderate sevirty (SCORAD below than 12)).Atopic dermatitis
- Registration Number
- IRCT2015062017994N1
- Lead Sponsor
- Sina Tejart Pishgam® company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria:
Case of Mild to moderate atopic dermatitis
Aged (>2) years old
At least 2 lesions on arms or legs with identical local SCORAD
Written Informed Consent
Having a negative pregnancy test
Willingness to actively participate in the study and to come to the scheduled visits respectively willingness of parents/legal guardians to actively participate in the study and to come to the scheduled visits
Willingness to discontinue the use of any conventional skin care products (e.g. creams, lotions, sunscreens) at the treatment areas of Linola F throughout the course of the study
Pregnancy or lactation
Severe Atopic eczema (local SCORAD >12)
Drug addicts, alcoholics
One of the following serious illnesses, if not medicated: cardiovascular diseases, asthma, hypertension
Active skin disease at test area (except atopic dermatitis)
Moles, tattoos, scars, hairs, dark pigmentation etc. at the test area that could influence the investigation
Documented allergies to cosmetic products
History of HIV
History of Hepatitis C
History of Hepatitis B
Being involved in any other research project /clinical trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Trans Epidermal Water Loss(TEWL). Timepoint: Visit 0, 2 week after Visit 0, 4 week after Visit 0. Method of measurement: MPA.;Corneometer. Timepoint: Visit 0, 2 week after Visit 0, 4 week after Visit 0. Method of measurement: MPA.
- Secondary Outcome Measures
Name Time Method SCORAD Measure. Timepoint: Visit 0, 2 week after Visit 0, 4 week after Visit 0. Method of measurement: SCORAD.;Burning, Iching, Temperature, Sebum, PH ,Mexameter. Timepoint: v. Method of measurement: MPA, calculating measures.;Thickness , Density. Timepoint: Visit 0, 2 week after Visit 0, 4 week after Visit 0. Method of measurement: Ultrasonography.;Satisfaction with the solution treatment. Timepoint: 2 week after Visit 0, 4 week after Visit 0. Method of measurement: questionnaire.